A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
Fabio DardiAlessandra ManesDaniele GuarinoElisa ZuffaAlessandro De LorenzisIlenia MagnaniMariangela RotunnoAlberto BalleriniGerardo Vito Lo RussoElena NardiNazzareno GalièMassimiliano PalazziniPublished in: Open heart (2022)
The simplified risk-assessment method can discriminate idiopathic, connective-tissue-disease-associated and congenital-heart-disease-associated PAH patients into meaningful high-risk, intermediate-risk and low-risk groups at baseline and first follow-up. This pragmatic approach reinforces targeting a low-risk profile for PAH patients.
Keyphrases
- risk assessment
- pulmonary arterial hypertension
- end stage renal disease
- congenital heart disease
- newly diagnosed
- ejection fraction
- prognostic factors
- peritoneal dialysis
- pulmonary hypertension
- heavy metals
- pulmonary artery
- patient reported outcomes
- acute kidney injury
- coronary artery
- clinical practice
- patient reported
- thoracic surgery